• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE VIABAHN ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE VIABAHN ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Catalog Number JHH111002J
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Occlusion (1984)
Event Date 03/01/2020
Event Type  Injury  
Event Description
The following was reported to gore: on (b)(6) 2020, the patient underwent endovascular treatment of a pseudoaneurysm at the left subclavian artery using gore® viabahn® endoprosthesis with heparin bioactive surface (viabahn).Two viabahn were placed and the procedure was completed without any issue.On (b)(6) 2020, the follow up ct imaging revealed blood clot inside the devices.The medication was changed from dapt (bayaspirin and plavix) to warfarin and aspirin.On (b)(6) 2020, it was observed that the stenosis due to blood clot inside the devices have been progressed.On (b)(6) 2020, reintervention was performed.Two additional stent grafts were placed inside the viabahns, and it was confirmed that no issue on the blood flow on the final angiography imaging.The procedure was completed, and the patient tolerated the procedure.
 
Manufacturer Narrative
A1: patient id: (b)(6).Additional manufacturer narrative: cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.Mrn#: 2017233-2020-01479 is referencing the same patient and procedure as this report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key10885818
MDR Text Key217709159
Report Number2017233-2020-01478
Device Sequence Number1
Product Code NIP
Combination Product (y/n)Y
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 09/13/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/28/2020
Device Catalogue NumberJHH111002J
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 11/02/2020
Initial Date FDA Received11/23/2020
Supplement Dates Manufacturer Received11/02/2020
Supplement Dates FDA Received09/13/2021
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age75 YR
-
-